609 related articles for article (PubMed ID: 26805671)
21. Systematic pathogenesis and replication of avian hepatitis E virus in specific-pathogen-free adult chickens.
Billam P; Huang FF; Sun ZF; Pierson FW; Duncan RB; Elvinger F; Guenette DK; Toth TE; Meng XJ
J Virol; 2005 Mar; 79(6):3429-37. PubMed ID: 15731237
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis E: an emerging global disease - from discovery towards control and cure.
Khuroo MS; Khuroo MS
J Viral Hepat; 2016 Feb; 23(2):68-79. PubMed ID: 26344932
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis E Virus Infects Neurons and Brains.
Zhou X; Huang F; Xu L; Lin Z; de Vrij FMS; Ayo-Martin AC; van der Kroeg M; Zhao M; Yin Y; Wang W; Cao W; Wang Y; Kushner SA; Marie Peron J; Alric L; de Man RA; Jacobs BC; van Eijk JJ; Aronica EMA; Sprengers D; Metselaar HJ; de Zeeuw CI; Dalton HR; Kamar N; Peppelenbosch MP; Pan Q
J Infect Dis; 2017 Apr; 215(8):1197-1206. PubMed ID: 28199701
[TBL] [Abstract][Full Text] [Related]
24. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.
Volz T; Allweiss L; Ben MBarek M; Warlich M; Lohse AW; Pollok JM; Alexandrov A; Urban S; Petersen J; Lütgehetmann M; Dandri M
J Hepatol; 2013 May; 58(5):861-7. PubMed ID: 23246506
[TBL] [Abstract][Full Text] [Related]
25. Cutthroat trout virus as a surrogate in vitro infection model for testing inhibitors of hepatitis E virus replication.
Debing Y; Winton J; Neyts J; Dallmeier K
Antiviral Res; 2013 Oct; 100(1):98-101. PubMed ID: 23916729
[TBL] [Abstract][Full Text] [Related]
26. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
[TBL] [Abstract][Full Text] [Related]
27. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
[TBL] [Abstract][Full Text] [Related]
28. Stem cell-derived hepatocytes: A novel model for hepatitis E virus replication.
Helsen N; Debing Y; Paeshuyse J; Dallmeier K; Boon R; Coll M; Sancho-Bru P; Claes C; Neyts J; Verfaillie CM
J Hepatol; 2016 Mar; 64(3):565-73. PubMed ID: 26626494
[TBL] [Abstract][Full Text] [Related]
29. Quantitative detection of hepatitis E virus RNA and dynamics of viral replication in experimental infection.
Li X; Kamili S; Krawczynski K
J Viral Hepat; 2006 Dec; 13(12):835-9. PubMed ID: 17109683
[TBL] [Abstract][Full Text] [Related]
30. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
[TBL] [Abstract][Full Text] [Related]
31. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
[TBL] [Abstract][Full Text] [Related]
32. Updates in Hepatitis E virus (HEV) field; lessons learned from human liver chimeric mice.
Sayed IM; Meuleman P
Rev Med Virol; 2020 Mar; 30(2):e2086. PubMed ID: 31835277
[TBL] [Abstract][Full Text] [Related]
33. An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.
Jin SE; Kim JE; Kim SY; Park BJ; Song YJ
J Microbiol; 2017 Dec; 55(12):984-988. PubMed ID: 29214492
[TBL] [Abstract][Full Text] [Related]
34. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
[TBL] [Abstract][Full Text] [Related]
35. Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice.
van de Garde MDB; Pas SD; van Oord GW; Gama L; Choi Y; de Man RA; Boonstra A; Vanwolleghem T
Sci Rep; 2017 Aug; 7(1):8267. PubMed ID: 28811492
[TBL] [Abstract][Full Text] [Related]
36. Cross-protection of hepatitis E virus genotypes 1 and 4 in rhesus macaques.
Huang W; Zhang H; Harrison TJ; Lang S; Huang G; Wang Y
J Med Virol; 2008 May; 80(5):824-32. PubMed ID: 18360896
[TBL] [Abstract][Full Text] [Related]
37. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
[TBL] [Abstract][Full Text] [Related]
38. Shift of hepatitis E virus RNA from hepatocytes to biliary epithelial cells during acute infection of rhesus monkey.
Kawai HF; Koji T; Iida F; Kaneko S; Kobayashi K; Nakane PK
J Viral Hepat; 1999 Jul; 6(4):287-97. PubMed ID: 10607243
[TBL] [Abstract][Full Text] [Related]
39. Capped RNA transcripts of full-length cDNA clones of swine hepatitis E virus are replication competent when transfected into Huh7 cells and infectious when intrahepatically inoculated into pigs.
Huang YW; Haqshenas G; Kasorndorkbua C; Halbur PG; Emerson SU; Meng XJ
J Virol; 2005 Feb; 79(3):1552-8. PubMed ID: 15650181
[TBL] [Abstract][Full Text] [Related]
40. Targeting proteostasis of the HEV replicase to combat infection in preclinical models.
Zhang F; Xu LD; Zhang Q; Wang A; Yu X; Liu S; Chen C; Wu S; Jin J; Lin A; Neculai D; Zhao B; Feng XH; Liang T; Xu P; Huang YW
J Hepatol; 2023 Apr; 78(4):704-716. PubMed ID: 36574921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
